“FREQUENCY AND CHARACTERISTICS OF ADVERSE EVENTS ASSOCIATED WITH ANTI-TUBERCULOSIS DRUGS DURING THE TREATMENT OF DRUG-RESISTANT PULMONARY TUBERCULOSIS”. 2026. Eureka Journal of Health Sciences & Medical Innovation 2 (6): 1-11. https://eurekaoa.com/index.php/5/article/view/1148.